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Summary
 
In mice deficient in either lymphotoxin 
 
a
 
 (LT-
 
a
 
) or type I tumor necrosis factor receptor
(TNFR-I), organized clusters of follicular dendritic cells (FDC) and germinal centers (GC) are
absent from the spleen. We investigated the role of LT-
 
a
 
 and TNFR-I in the establishment of
spleen FDC and GC structure by using reciprocal bone marrow (BM) transfer. When LT-
 
a
 
–deficient mice were reconstituted with wild-type BM, FDC organization and the ability to
form GC were restored, indicating that the LT-
 
a
 
–expressing cells required to establish orga-
nized FDC are derived from BM. The role of LT-
 
a
 
 in establishing organized FDC structure
was further investigated by the transfer of complement receptor 1 and 2 (CR1/2)–deficient
BM cells into LT-
 
a
 
–deficient mice. Organized FDC were identified with both the FDC-M1
and anti-CR1 monoclonal antibodies in these BM-chimeric mice, indicating that these cells
were derived from the LT-
 
a
 
–deficient recipient. Thus, expression of LT-
 
a
 
 in the BM-derived
cells, but not in the non–BM-derived cells, is required for the maturation of FDC from non-
BM precursor cells. In contrast, when TNFR-I–deficient mice were reconstituted with wild-
type BM, they showed no detectable FDC clusters or GC formation. This indicates that
TNFR-I expression on non–BM-derived cellular components is necessary for the establish-
ment of these lymphoid structures. TNFR-I–deficient BM was able to restore FDC organiza-
tion and GC formation in LT-
 
a
 
–deficient mice, indicating that formation of these structures
does not require TNFR-I expression on BM-derived cells. The data in this study demonstrate
that FDC organization and GC formation are controlled by both LT-
 
a
 
–expressing BM-derived
cells and by TNFR-I-expressing non–BM-derived cells.
 
L
 
ymphotoxin (LT)
 
1
 
-
 
a
 
 and TNF-
 
a
 
 are structurally re-
lated cytokines that can modulate many immune and
inflammatory reactions (1–3). In solution, LT-
 
a
 
 exists as a
homotrimer. TNF-
 
a
 
 is also a homotrimer, synthesized first
as a type II membrane protein that can be released from
cells in a soluble form by the action of the TNF-
 
a
 
–con-
verting enzyme (4–7). The LT-
 
a
 
 and TNF-
 
a
 
 homotrimers
can each engage and activate the same two plasma mem-
brane receptors: the 55-kD TNF receptor (TNFR type I)
and the 75-kD TNF receptor (TNFR type II) (8, 9). LT
can also exist in a membrane-associated form, which in its
major form consists of an LT-
 
a
 
 monomer and two identical
33-kD transmembrane LT-
 
b
 
 subunits (10–12). Membrane
LT binds and activates the recently identified LT-
 
b
 
 receptor
(LT-
 
b
 
R) and has no measurable affinity for TNFR-I or -II
(13, 14).
Recent studies using mouse strains deficient in either
LT-
 
a
 
, LT-
 
b
 
, or TNF-
 
a
 
 have demonstrated that LT-
 
a
 
 and
-
 
b
 
 have actions that are distinct from those of TNF-
 
a
 
.
Mice rendered deficient in either LT-
 
a
 
 or -
 
b
 
 are born
with a dramatic impairment of lymph node (LN) biogene-
sis (15–18). In contrast, mice deficient in TNF-
 
a
 
 (19), like
mice deficient in either TNFR-I or -II, have grossly nor-
mal LN structures (20–22). Thus, the actions of LT-
 
a
 
 and
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; FDC, follicular den-
dritic cell(s); GC, germinal center(s); IC, immune complex; LN, lymph
node; LT, lymphotoxin; PNA, peanut agglutinin; TNFR, TNF receptor.
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-
 
b
 
 in LN biogenesis are not dependent on signaling by ei-
ther of the two TNF receptors, but rather most likely by a
receptor for the membrane LT heteromer. The potential
role of membrane LT is supported by additional recent
studies by Rennert et al. (23) in which a soluble form of
the LT-
 
b
 
R administered to mice during the latter portions
of gestation blocked LN development in offspring. Further
studies of LT-
 
a
 
–, LT-
 
b
 
–, and TNFR-I–targeted mice have
revealed other important roles of LT or TNFR-I in the es-
tablishment of lymphoid organ structure. Firstly, LT-
 
a
 
–,
LT-
 
b
 
–, and TNFR-I–deficient mice all manifest abnormal
Peyer’s patch (PP) development (15–18, 24). The absence
of normal PP structure in the presence of LN in TNFR-
I–deficient mice suggests that TNFR-I may act in lym-
phoid organogenesis in an organ-specific fashion. Secondly,
LT-
 
a
 
–, LT-
 
b
 
–, TNF-
 
a
 
–, and TNFR-I–deficient mice all fail
to form germinal centers (GC) in the spleen (17–19, 25–27).
GC are histologically well defined structures that de-
velop in secondary lymphoid organs shortly after challenge
with T cell–dependent antigens (28). It has been suggested
that it is within GC that somatic hypermutation and affinity
maturation of the antibody response occur (29–31). In a pre-
vious study, we investigated the mechanism of the defect of
GC formation in LT-
 
a
 
–deficient mice through use of re-
ciprocal bone marrow (BM) transfers (25). This study dem-
onstrated that reconstitution of lethally irradiated LT-
 
a
 
–
deficient mice with normal BM restored the ability to form
GC. In contrast, when LT-
 
a
 
–deficient BM cells were used
to reconstitute irradiated wild-type mice, GC formation was
defective, as in the LT-
 
a
 
–deficient mice. These data indi-
cate that BM-derived cells are the only essential source of
LT-
 
a
 
 required for the formation of GC.
Both primary and secondary lymphoid follicles charac-
teristically contain clusters of follicular dendritic cells (FDC;
reference 32). FDC trap and can retain antigen–antibody
complexes for long periods (33), apparently by means of re-
ceptors for the third complement component (CR) as well as
Fc
 
g
 
 receptors (32). We and others have shown that orga-
nized FDC structure, a major morphological characteristic
of GC, is absent in LT-
 
a
 
–, LT-
 
b
 
–, TNF-
 
a
 
–, and TNFR-
I–deficient mice (17–19, 26, 27, 34, 35).
In this study, we have investigated the role of LT-
 
a
 
 and
TNFR-I in the establishment of follicle structure in the
spleen through use of reciprocal BM transfers. This study
defines distinct roles of LT-
 
a
 
 and TNFR-I in the organiza-
tion of these lymphoid tissue structures and demonstrates
clearly that FDC are not transferred to adult animals by
BM, but rather develop in transplant recipients from non-
BM precursor cells.
 
Materials and Methods
 
Mice.
 
LT-
 
a
 
– and CR1/2-deficient mice were generated as
previously described (15, 36). TNFR-I–deficient mice (37) were
provided by J. Peschon (Immunex, Seattle, WA). The mice were
maintained and bred in the Division of Comparative Medicine,
Washington University School of Medicine, under pathogen-free
conditions. All experiments were initiated with 8–12-wk-old mice.
 
Bone Marrow Transfer.
 
BM transfer was performed as previ-
ously described (38). In brief, BM cells were harvested by flushing
the femurs of donor mice with RPMI 1640 medium (GIBCO/
BRL, Gaithersburg, MD) supplemented with 10% heat-inactivated
fetal bovine serum (HyClone, Logan, UT), 2 mM 
 
l
 
-glutamine,
100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin, hereafter re-
ferred to as R10. Cells were washed once and suspended in R10
medium containing anti-Thy1.2 mAb (clone 5a-8; Accurate
Chemical & Scientific Corporation, Westbury, NY) plus low-
toxic rabbit complement (Accurate Chemical & Scientific Corpo-
ration). After incubation at 37
 
8
 
C for 45 min, cells were washed
twice and adjusted to 3 
 
3
 
 10
 
7
 
 viable cells/ml in R10. Each recip-
ient mouse was lethally irradiated (10 Gy) and treated with 0.5 ml
of donor BM cells intravenously on the same day. These recipient
mice were used for analysis 6–10 wk after BM transfer.
 
Immunohistochemistry.
 
Mice were immunized intraperitoneally
with 100 
 
m
 
l of PBS (pH 7.4) containing 10% sheep red blood
cells. 10 d later, spleens were harvested, and frozen tissue sections
were prepared. Immunohistochemistry using peanut agglutinin
(PNA; Vector, Burlingame, CA), anti-B220 mAb (PharMingen,
San Diego, CA) and anti-CR mAbs (8C12, 7G6, and 7E9; refer-
ence 39), and immune complex (IC) trapping in vitro were per-
formed as previously described (25, 34, 40). For the combination
of IC trapping in vitro and staining with anti-B220 mAb, frozen
sections were first incubated with 1:10 diluted mouse horseradish
peroxidase (HRP)–anti-peroxidase complex (code B650, lot 035A;
DAKO A/S, Glostrup, Denmark) in the presence of 1:5 diluted
fresh mouse serum as a source of complement. After washing in PBS,
sections were further incubated with anti-B220-biotin and then
with streptavidin conjugated with alkaline phosphatase (AP) (Zymed,
South San Francisco, CA). Color development for bound AP and
HRP was with an AP reaction kit (Vector) and with diaminoben-
zidine.
 
Results
 
Role of LT-
 
a
 
 in the Organization of FDC.
 
The role of
LT-
 
a
 
 in the organization of FDC was studied using recip-
rocal BM transfer experiments. 6–10 wk after BM transfer,
FDC organization in these BM-chimeric mice was visual-
ized immunohistochemically by using 8C12, an mAb specific
for murine CR1 (39). LT-
 
a
 
–deficient mice reconstituted
with normal BM demonstrated prominent FDC reticula in
the GC light zones (Fig. 1 
 
A
 
). Similar results were obtained
using the anti-FDC mAbs FDC-M1 and FDC-M2 (41)
 
Figure 1.
 
Restoration of organized FDC clusters and GC in LT-
 
a
 
–deficient mice after transplantation with normal BM. After BM transfer, mice were im-
munized intraperitoneally with 100 
 
m
 
l of PBS containing 10% sheep red blood cells. 10 d later, spleens were harvested and frozen sections were stained
with (
 
A–D
 
) anti-CR1 antibody 8C12 (
 
blue
 
) and PNA (
 
brown
 
), or (
 
E–H
 
) with horseradish peroxidase–anti-peroxidase complex (
 
brown
 
) and anti-B220 (
 
blue
 
). (
 
A
 
and 
 
E
 
) LT-
 
a
 
–deficient mice reconstituted with wild-type BM showed restored FDC clusters and an ability to form GC. (
 
B
 
 and 
 
F
 
) Conversely, wild-type
mice reconstituted with LT-
 
a
 
–deficient BM showed no detectable FDC clusters or formation of GC. Wild-type mice reconstituted with wild-type BM (
 
C
 
and 
 
G
 
) and LT-
 
a–deficient mice reconstituted with LT-a–deficient BM (D and H) showed similar anti-CR1 staining and in vitro IC trapping compared to
wild-type mice and LT-a–deficient mice, respectively. Original magnification, 3100.1999 Matsumoto et al.2000 Distinct Roles of LT-a and TNFR-I in the Induction of FDC
and 7G6 or 7E9, mAbs specific for murine CR1 and CR2
(data not shown). FDC organization was further assessed by
analysis of IC trapping using spleen sections from these ani-
mals. Consistent with the result obtained from anti-CR1
staining, IC trapping was demonstrated at sites correspond-
ing to the FDC reticula in these mice (Fig. 1 E). Thus, res-
toration of GC formation in wild-type BM-reconstituted
LT-a–deficient mice was associated with de novo develop-
ment of organized FDC structure. In contrast, wild-type
mice reconstituted with LT-a–deficient BM showed no
clusters of anti-CR1 staining cells or PNA1 cells (Fig. 1 B),
and showed absence of IC trapping (Fig. 1 F). Wild-type
mice reconstituted with wild-type BM (Fig. 1, C and G)
and LT-a–deficient mice reconstituted with LT-a–defi-
cient BM (Fig. 1, D and H) showed similar anti-CR1
staining and in vitro IC trapping compared to wild-type
mice and LT-a–deficient mice, respectively.
Although the precise lineage from which FDC differen-
tiate is unknown, several pieces of data suggest that FDC
are not BM-derived cells (32, 42, 43). Because transferred
LT-a–expressing BM-derived cells can induce both the
formation of FDC clusters and the formation of GC in LT-
a–deficient recipient mice, we speculate that functional
FDC precursors are present in the spleen or other tissues of
LT-a–deficient mice. These cells can be induced to form
mature FDC clusters once an LT-a–dependent signal is
provided by the transferred BM cells.
To further demonstrate the role of LT-a as a signal re-
quired to establish organized FDC structure and to investi-
gate the cell lineage of FDC, we used BM cells from CR1/
2-deficient mice to reconstitute irradiated LT-a–deficient
mice. In this context, donor CR1/2-deficient BM-derived
cells are LT-a wild type, but can be distinguished from the
LT-a–deficient recipient cells by their failure to stain with
anti-CR1 mAb (36). After reconstitution, spleen sections
were stained with anti-CR1 mAb and PNA to assay for the
presence of FDC clusters and GC. Similar to the results ob-
tained after transfer of wild-type BM cells, clustered FDC
were identified with anti-CR1 mAb after transfer of CR1/
2-deficient BM (Fig. 2 A). These FDC were able to sup-
port the formation of typical CR1/2-expressing GC (Fig. 2
B). These results clearly indicate that the clustered FDC in-
duced in these BM-chimeric mice are derived from the
LT-a–deficient recipient, and that LT-a provides a signal
that supports the development of FDC clusters. These re-
sults also indicate that the lack of organized FDC structure
in LT-a–deficient mice is a plastic characteristic deter-
mined by the LT-a expression status of the BM-derived
cells populating the animal.
Role of TNFR-I in the Development of FDC Clusters and
GC. TNFR-I–deficient mice also lack FDC clusters and
spleen GC formation (25, 26). To investigate the mecha-
nism of this structural defect in the TNFR-I–deficient mice,
we performed similar reciprocal BM transfer experiments.
In contrast to the LT-a–deficient mice, reconstitution of
TNFR-I–deficient mice with wild-type BM did not re-
store the organization of FDC clusters or the formation of
GC (Fig. 3, A and C). This suggests that development of
normal clusters of FDC in the spleen requires TNFR-I ex-
pression on some radioresistant non–BM-derived compo-
nent(s) in the recipient mouse, most likely a cellular ele-
ment within the spleen itself. Alternatively, the failure to
restore FDC clusters in TNFR-I–deficient mice after transfer
of normal BM might indicate that essential TNFR-I–depen-
dent interactions may be required within a developmental
window before 8–12 wk of age, when these BM transfers
were performed.
Conversely, when irradiated wild-type mice were re-
constituted with BM cells from TNFR-I–deficient mice,
both organized FDC clusters and morphologically normal
Figure 2. FDC clusters induced after BM transfers are non–BM-derived. When BM from CR1/2-deficient mice was used to reconstitute LT-a–defi-
cient mice, FDC clusters, which stained with anti-CR1 mAb, formed. These FDC clusters supported the development of PNA1 GC. After BM transfer,
mice were immunized and spleens were harvested as described in Fig. 1. (A) Staining was with anti-CR1 (blue) and anti-B220 (brown). (B) Staining was
with PNA (blue) and anti-B220 (brown). Original magnification, 3100.2001 Matsumoto et al.
GC formed (Fig. 3, B and D). Additionally, these chimeric
mice demonstrated robust trapping of IC at sites correspond-
ing to the FDC reticula (data not shown). This suggests
that neither the development of FDC clusters nor the for-
mation of GC requires expression of TNFR-I on BM-derived
cells.
Distinct Roles of LT-a and TNFR-I in Development of
FDC Clusters. These data demonstrate that LT-a pro-
duced by BM-derived cells is required for the organization
of FDC clusters, but that expression of LT-a is not re-
quired by the FDC themselves or their precursors. In con-
trast, the development of FDC clusters requires expression
of TNFR-I on non–BM-derived cells, but not on BM-
derived cells. Thus, clustering of FDC within spleen lymphoid
follicles is controlled by at least two distinct cell popula-
tions, one defined by the expression of LT-a and the other
defined by the expression of TNFR-I. To confirm that the
requirement for LT-a and TNFR-I was a manifestation of
the need for at least two distinct cell populations, we trans-
ferred BM cells from TNFR-I deficient donor mice (LT-a
wild-type) into irradiated LT-a–deficient recipients (TNFR-I
wild-type). Organized FDC clusters and the ability to form
GC were demonstrated in these mice (Fig. 4, A and B).
These results confirmed that neither expression of TNFR-I
on the BM-derived cells nor of LT-a by radioresistant cells
in the recipient is necessary for the development of FDC
clusters or GC.
Discussion
Our results demonstrate that both LT-a produced by
BM-derived cells and TNFR-I expressed by some non–
BM-derived cells are required for the development of FDC
clusters in the spleen. Because TNFR-I is strongly ex-
pressed on the FDC themselves (44) and because FDC are
non–BM-derived, as demonstrated in this study, we spec-
Figure 3. Failure to restore organized FDC clusters and development of GC in TNFR-I–deficient mice by transplantation with normal BM. (A and C)
TNFR-I–deficient mice reconstituted with wild-type BM showed no detectable FDC clusters or GC. (B and D) Wild-type mice reconstituted with
TNFR-I–deficient BM showed FDC clusters and GC formation. After BM transfer, mice were immunized and spleens were harvested as described in
Fig. 1. (A and B) Staining was with anti-CR1 antibody 8C12 (blue) and anti-B220 (brown). (C and D) Staining was with PNA (blue) and anti-B220
(brown). Original magnification, 3100.2002 Distinct Roles of LT-a and TNFR-I in the Induction of FDC
ulate that the FDC themselves or their lineage precursors
are the recipient cells that require signaling directly through
TNFR-I for establishment of organized clusters. The in-
ability of wild-type BM to restore clustered FDC organiza-
tion after transfer into TNFR-I–deficient mice is consistent
with this hypothesis.
The presence or absence of FDC clusters is not an intrin-
sically fixed morphological feature. Plasticity of FDC clus-
ters is seen in LT-a–deficient mice, in which clusters of
FDC can be restored by reconstitution with LT-a–express-
ing BM. This implies that the precursors of clustered FDC
cells that respond to an LT-a–dependent signal by forma-
tion of mature FDC clusters remain present in LT-a–defi-
cient animals even in the absence of an LT-a signal. Thus,
LT-a is not absolutely required for the production of the
FDC lineage, but rather it is necessary for its maturation or
for organization of the mature cells. In this context, it is of
interest that mice transgenic for expression of LT-a driven
by the rat insulin promoter develop chronic inflammatory
lesions and that these lesions manifest clustered FDC within
the cellular infiltrate (45). Currently, whether the LT-a acts
as the soluble homotrimer or as a component of the mem-
brane LT heteromer, and which LT-sensitive receptor de-
termines this phenotype remain unknown in this transgenic
model.
Although the identification of similarly disturbed FDC
clustering in both LT-a– and TNFR-I–deficient mice is
consistent with the possibility that LT-a (presumably in its
secreted homotrimeric form) acts to regulate FDC organi-
zation by binding directly to TNFR-I, the recent observa-
tions that both TNF-a–deficient and LT-b–deficient mice
also manifest absence of FDC clusters (17–19) demonstrate
that both the LT axis and the TNF-a axis are required for
the development of this structure, and underscores the like-
lihood that LT-a signals as a component of the membrane
LT heteromer via a receptor distinct from TNFR-I, such as
the LT-bR. This latter possibility is supported by the ob-
servation that LT-a appears to contribute to the develop-
ment of other aspects of spleen follicle structure by interac-
tion through a receptor other than TNFR-I or -II. We
have observed that LT-a contributes to the formation of a
morphologically normal marginal zone in the spleen; stain-
ing with MOMA-1, an mAb specific for the metallophilic
macrophages that constitute a major component of the mar-
ginal zone (46), was essentially absent in LT-a–deficient
mice, whereas the pattern of MOMA-1 staining in TNFR-I–
or TNFR-II–deficient mice was indistinguishable from
that in wild-type mice (25). Analysis of mice carrying tar-
geted mutation in the LT-bR gene should permit clear
definition of the role of these TNF/TNFR family mem-
bers in the establishment of the lymphoid organ structure.
In the BM transfer experiments reported here, the resto-
ration of GC structure in LT-a–deficient mice reconsti-
tuted with wild-type BM was associated with restoration of
organized FDC clusters; however, when total splenocytes
from wild-type donors were transferred into irradiated LT-
a–deficient mice, the LT-a–deficient recipients manifested
in their spleen follicles the presence of clusters of PNA1 B
cells typical of GC but without detectable clustered FDC
(Fu, Y.-X., G. Huang, and D.D. Chaplin, unpublished data).
This suggests that LT-a acts additionally to provide a signal
for the development or maintenance of proliferating clus-
ters of PNA1 B cells. In this short term reconstitution model,
this proliferation is not dependent on the presence of FDC
clusters. These data suggest that the signals leading to the
formation of a fully functional GC are complex, and that GC
formation may occur in discrete stages, several of which are
controlled by members of the TNF/TNFR family.
Figure 4. Restoration of organized FDC clusters and GC formation in LT-a–deficient mice reconstituted with TNFR-I–deficient BM. After BM
transfer, mice were immunized and spleens were harvested as described in Fig. 1. Serial sections are shown. (A) Staining was with anti-CR1 (blue) and
anti-B220 (brown). (B) Staining is with PNA (blue) and anti-B220 (brown). Original magnification, 3100.2003 Matsumoto et al.
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